Method for producing optically active isopulegol and optically active menthol
US-2015329452-A1 · Nov 19, 2015 · US
US2016347678A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016347678-A1 |
| Application number | US-201515117333-A |
| Country | US |
| Kind code | A1 |
| Filing date | Feb 13, 2015 |
| Priority date | Feb 14, 2014 |
| Publication date | Dec 1, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention pertains to a method for producing an optically active compound which includes a step for reducing an imino group of an imine compound or a step for reducing an unsaturated bond of a heterocyclic compound, while in the presence of hydrogen gas as a hydrogen donor and one or more types of complexes selected from a group consisting of a complex represented by general formula (1), a complex represented by general formula (2), a complex represented by general formula (3), and a complex represented by general formula (4) (the general formulas (1)-(4) are as stipulated by claim 1 ).
Opening claim text (preview).
1 . A method for producing an optically active compound, comprising the step of: reducing an imino group of an imine compound or reducing an unsaturated bond of a heterocyclic compound in the presence of at least one complex selected from complexes represented by general formula (1) below, complexes represented by general formula (2) below, complexes represented by general formula (3) below, and complexes represented by general formula (4) below and of hydrogen gas serving as a hydrogen donor: wherein * indicates an asymmetric carbon atom, R 1 represents a group selected from alkyl groups having 1 to 10 carbon atoms, halogenated alkyl groups having 1 to 10 carbon atoms, and aryl groups having 6 to 30 carbon atoms, wherein said aryl groups may have one or more substituents selected from alkyl groups having 1 to 10 carbon atoms, halogenated alkyl groups having 1 to 10 carbon atoms, and halogen atoms, R 2 and R 3 each independently represent a group selected from alkyl groups having 1 to 10 carbon atoms, phenyl groups, and cycloalkyl groups having 3 to 8 carbon atoms, wherein said phenyl groups may have one or more substituents selected from alkyl groups having 1 to 10 carbon atoms, alkoxy groups having 1 to 10 carbon atoms, and halogen atoms, and wherein said cycloalkyl groups may have one or more substituents selected from alkyl groups having 1 to 10 carbon atoms, or R 2 and R 3 form a ring together with the carbon atoms to which R 2 and R 3 are bonded, Y represents a hydrogen atom or a deuterium atom, R 11 , R 12 , R 13 , R 14 , R 15 , and R 16 each independently represent a group selected from a hydrogen atom, alkyl groups having 1 to 10 carbon atoms, silyl groups having 1 to 3 alkyl groups having 1 to 10 carbon atoms, alkoxy groups having 1 to 10 carbon atoms, and —C(═O)—OR 22 , wherein R 22 represents an alkyl group having 1 to 10 carbon atoms, a heteroaryl group having 4 to 10 carbon atoms, or an aryl group having 6 to 10 carbon atoms, and Q − represents a counter anion; wherein * indicates an asymmetric carbon atom, R 1 , R 2 , R 3 , R 11 , R 12 , R 13 , R 14 , R 15 , R 16 , and Y are as defined above, A represents a group selected from a trifluoromethanesulfonyloxy group, a p-toluenesulfonyloxy group, a methanesulfonyloxy group, a benzenesulfonyloxy group, a hydrogen atom, a deuterium atom, and halogen atoms, and j and k each represent 0 or 1, provided that j+k is not 1; wherein * indicates an asymmetric carbon atom, R 1 , R 2 , R 3 , A, and Y are as defined above, M represents iridium or rhodium, L represents a cyclopentadienyl or pentamethylcyclopentadienyl ligand, and j and k each represent 0 or 1, provided that j+k is not 1; and wherein * indicates an asymmetric carbon atom, and R 1 , R 2 , R 3 , Y, M, L, and Q − are as defined above. 2 . A ruthenium complex represented by general formula (1): wherein * indicates an asymmetric carbon atom, R 1 represents a group selected from alkyl groups having 1 to 10 carbon atoms, halogenated alkyl groups having 1 to 10 carbon atoms, and aryl groups having 6 to 30 carbon atoms, wherein said aryl groups may have one or more substituents selected from alkyl groups having 1 to 10 carbon atoms, halogenated alkyl groups having 1 to 10 carbon atoms, and halogen atoms, R 2 and R 3 each independently represent a group selected from alkyl groups having 1 to 10 carbon atoms, phenyl groups, and cycloalkyl groups having 3 to 8 carbon atoms, wherein said phenyl groups may have one or more substituents selected from alkyl groups having 1 to 10 carbon atoms, alkoxy groups having 1 to 10 carbon atoms, and halogen atoms, and wherein said cycloalkyl groups may have one or more substituents selected from alkyl groups having 1 to 10 carbon atoms, or R 2 and R 3 form a ring together with the carbon atoms to which R 2 and R 3 are bonded, Y represents a hydrogen atom or a deuterium atom, R 11 , R 12 , R 13 , R 14 , R 15 , and R 16 each independently represent a group selected from a hydrogen atom, alkyl groups having 1 to 10 carbon atoms, silyl groups having 1 to 3 alkyl groups having 1 to 10 carbon atoms, alkoxy groups having 1 to 10 carbon atoms, and —C(═O)—OR 22 , wherein R 22 represents an alkyl group having 1 to 10 carbon atoms, a heteroaryl group having 4 to 10 carbon atoms, or an aryl group having 6 to 10 carbon atoms, and Q − represents a counter anion. 3 . An iridium or rhodium complex represented by general formula (4): wherein * indicates an asymmetric carbon atom, R 1 represents a group selected from alkyl groups having 1 to 10 carbon atoms, halogenated alkyl groups having 1 to 10 carbon atoms, and aryl groups having 6 to 30 carbon atoms, wherein said aryl groups may have one or more substituents selected from alkyl groups having 1 to 10 carbon atoms, halogenated alkyl groups having 1 to 10 carbon atoms, and halogen atoms, R 2 and R 3 each independently represent a group selected from alkyl groups having 1 to 10 carbon atoms, phenyl groups, and cycloalkyl groups having 3 to 8 carbon atoms, wherein said phenyl groups may have one or more substituents selected from alkyl groups having 1 to 10 carbon atoms, alkoxy groups having 1 to 10 carbon atoms, and halogen atoms, and wherein said cycloalkyl groups may have one or more substituents selected from alkyl groups having 1 to 10 carbon atoms, or R 2 and R 3 form a ring together with the carbon atoms to which R 2 and R 3 are bonded, Y represents a hydrogen atom or a deuterium atom, M represents iridium or rhodium, L represents a cyclopentadienyl or pentamethylcyclopentadienyl ligand, and Q − represents a counter anion. 4 . An asymmetric reduction catalyst comprising the complex according to claim 2 . 5 . An asymmetric reduction catalyst comprising the complex according to claim 3 .
Asymmetric syntheses · CPC title
Ruthenium compounds · CPC title
with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring · CPC title
containing carbocyclic rings other than six-membered · CPC title
condensed with one six-membered ring · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.